Opportunities Movement Disorders Market: Hospitals to Generate Significant Revenues through 2026

Fact.MR Fact.MR

Rockville, US, 2018-May-16 — /EPR Network/ — Recently, a novel report developed using proven research methodologies at the headquarters of Fact. MR has identified various prominent factors and trends prompting market growth of global movement disorders market. The study is titled as Movement Disorder Market Research Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2026, which deeply analyses the global market trends, with historical data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) during the mentioned forecast of 2017-2026. For the benefit of the readers, the report concludes with a special focus on the detailed profiles of the major vendors in the global movement disorders market.

Get A Free Sample Copy of Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=329

Factors Fueling Global Market Growth

Growth of the global movement disorders market is projected to be bound by various macro-economic and micro-economic factors. Lack of ability to move due to growing prevalence of factors such as cerebrovascular diseases, trauma, brain tumors, degenerative diseases and convulsive diseases continues to impact the global market growth of movement disorder positively. Prevalence of neurological disorders negatively affect the cognitive abilities and lead to depression, incapability to chew, swallowing, speaking and insomnia. Growing awareness regarding the prevalence of various mental diseases will further contribute towards the global market growth of movement disorder significantly.

Treatments and medications that have received an approval from FDA will further impact the global market growth of movement disorders positively. Ingrezza capsules and Xadago (safinamide) tablets are two medicines that have received an approval from FDA recently. Xadago (safinamide) tablets has been approved for the treatment of Parkinson’s disease and Ingrezza capsules has been approved for the treatment of dyskinesia. Moreover, FDA has approved brain transplantation in order to reduce various symptoms of tremor. Such factors continue to impact the global market growth of movement disorder significantly.

Sales to Remain High in Hospitals

Treatment of various neurological diseases has led to surge in adoption of the rechargeable deep brain stimulator devices. The rechargeable deep brain stimulator devices is projected to outsell the non-rechargeable deep brain stimulator devices globally. On the basis of product type, the rechargeable deep brain stimulator devices is projected to witness the highest growth in terms of revenue, recording more than US$ 500 Mn by 2026-end. On the other hand, the non-rechargeable deep brain stimulator devices product type segment is projected to reflect a robust CAGR throughout the forecast period.

By end user, the hospitals segment is projected to represent a robust revenue growth, accounting for less than US$ 100 Mn by 2017-end. In contrary to this, the clinics end user segment is projected to reflect a healthy CAGR during the forecast period. In terms of revenue, the parkinson’s disease application segment is projected to witness a significant revenue growth, recording more than US$ 400 Mn by 2026-end. By 2026-end, the dystonia application segment is projected to witness the fastest growth during the forecast period.

Market Players

Major players in the global market of movement disorder are Abbott Laboratories, Medtronic Plc, Mayo Clinic and Boston Scientific Corporation.

Browse Full Report with TOC@ https://www.factmr.com/report/329/movement-disorder-market

Table of Contents:

Chapter 1 Global Outlook

Chapter 2 Global Movement Disorder Market – Executive Summary

Chapter 3 Global Movement Disorder Market Overview
3.1 Introduction
3.1.1 Global Movement Disorder Market Taxonomy
3.1.2 Global Movement Disorder Market Definition
3.2 Global Movement Disorder Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1 Global Movement Disorder Market Y-o-Y Growth
3.3 Global Movement Disorder Market Dynamics
3.4 Supply Chain
3.5 Cost Structure
3.6 Technology Roadmap
3.7 Disease Epidemiology
3.8 Product Lifecycle
3.9 Key Regulations
3.10 PESTL Analysis
3.11 List of Service Providers
3.12 Key Participants Market Presence (Intensity Map) By Region

Chapter 4 Global Movement Disorder Market Analysis and Forecast 2012-2026
4.1 Global Movement Disorder Market Size and Forecast by Product Type, 2012-2026
4.1.1 Rechargeable Deep Brain Stimulator Devices Market Size and Forecast, 2012-2026
4.1.1.1 Revenue (US$ Mn) Comparison, By Region
4.1.1.2 Market Share Comparison, By Region
4.1.1.3 Y-o-Y growth Comparison, By Region

Continued………

Check Discount on this Report@ https://www.factmr.com/connectus/sample?flag=D&rep_id=329

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Get More Industry Insights At: https://www.linkedin.com/company/factmr

Matched content

Editor’s pick